dc.contributor.author | Mburu, DN | |
dc.contributor.author | Maitho, TE | |
dc.contributor.author | Lökken, P | |
dc.date.accessioned | 2013-06-13T12:36:10Z | |
dc.date.available | 2013-06-13T12:36:10Z | |
dc.date.issued | 1990 | |
dc.identifier.citation | Mburu DN, Maitho TE, Lökken P (1990). Acetylsalicylic acid or paracetamol? | en |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/2390952 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/33110 | |
dc.description.abstract | Paracetamol, a widely used non-narcotic analgesic, has the same analgesic, and antipyretic efficacy as acetylsalicylic acid (ASA). In contrast to ASA, paracetamol has traditionally been claimed to have little or no anti-inflammatory effect. There is, however, increasing support for the view that paracetamol has anti-inflammatory activity and reduces pain and swelling in inflammatory conditions other than rheumatoid arthritis. Overall, paracetamol seems to be equally effective as ASA. Since ASA has a greater potential for adverse effects, paracetamol is increasingly preferred to ASA, particularly in children. | en |
dc.language.iso | en | en |
dc.title | Acetylsalicylic acid or paracetamol? | en |
dc.type | Article | en |
local.publisher | Department of Public Health, Pharmacology and Toxicology, University of Nairobi, Kenya. | en |